ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

New Therapeutic Modalities In Testing For Patients With Carcinoid Syndrome

November 28, 2003

ASCO TO NCI: Review Auditing Procedures, Re-Establish Trust

May 27, 1994

A Patchwork Of Policies Emerges As Insurers Tighten Payments For ESAs.

March 30, 2007

Clinical Sciences Director Liu To Head Singapore Program.

January 12, 2001

In Congress; GAO Says Some Yew Bark Lost In ’91, But Problems Are Being Corrected

September 11, 1992

Researchers Uncover Tumors Sensitive to Chemotherapy

January 25, 2013